No increased risk of malignancies and mortality in cyclosporin A- treated patients with rheumatoid arthritis

Arthritis and Rheumatism

Volumn 41, Issue 11, 1998, Pages 1930-1937

  Van Den Borne, B E E M ^a   Landewe R B M ^b   Houkes, I ^a   Schild, Houkes F ^a   Van Der Heyden, P C W ^a   Hazes, J M W ^a   Vandenbroucke, J P ^a   Zwinderman, A H ^a   Goei The, H S ^b   Breedveld, F C ^a   Moens, H J Bernelot ^c   Kluin, P M ^a   Dijkmans, B A C ^d  

^a LEIDEN UNIVERSITY MEDICAL CENTER   (Netherlands)

^b Department of Medical Microbiology   (Netherlands)

^c MEDISCH SPECTRUM TWENTE   (Netherlands)

^d VU UNIVERSITY MEDICAL CENTER   (Netherlands)

Author keywords

[No Author keywords available]

Indexed keywords

CYCLOSPORIN A;

ADULT; AGED; ARTICLE; CANCER MORTALITY; CANCER RISK; CLINICAL TRIAL; COHORT ANALYSIS; CONTROLLED STUDY; DATA ANALYSIS; FEMALE; FOLLOW UP; HUMAN; MAJOR CLINICAL STUDY; MALE; PATHOGENESIS; PRIORITY JOURNAL; REGRESSION ANALYSIS; RETROSPECTIVE STUDY; RHEUMATOID ARTHRITIS; RISK FACTOR; SKIN CANCER; STATISTICAL ANALYSIS; TREATMENT OUTCOME;

ADULT; AGED; ANTIRHEUMATIC AGENTS; ARTHRITIS, RHEUMATOID; COHORT STUDIES; COMORBIDITY; CYCLOSPORINE; FEMALE; HUMANS; MALE; MIDDLE AGED; NEOPLASMS; RETROSPECTIVE STUDIES; RISK FACTORS; SURVIVAL ANALYSIS; TREATMENT OUTCOME;

EID: 17344362950     PISSN: 00043591     EISSN: None     Source Type: Journal    
DOI: 10.1002/1529-0131(199811)41:11<1930::AID-ART6>3.0.CO;2-N     Document Type: Article

References (25)

1. Kahan BD. Cyclosporine. N Engl J Med 1989;321:1725-38.
2. Hanto DW, Frizzera G, Gajl-Peczalska KJ, Sakamoto K, Purtilo DT, Balfour HH Jr, et al. Epstein-Barr virus-induced B-cell lymphoma after renal transplantation: acyclovir therapy and transition from polyclonal to monoclonal B-cell proliferation. N Engl J Med 1982;306:913-8.
3. Penn I. Cancers complicating organ transplantation. N Engl J Med 1990;323:1767-9.
4. Barr BB, Benton EC, McLaren K, Bunney MH, Smith IW, Blessing K, et al. Human papilloma virus infection and skin cancer in renal allograft recipients. Lancet 1989;1:124-9.
5. Bouwes Bavinck JN, Vermeer BJ, van der Woude FJ, Vandenbroucke JP, Schreuder GM, Thorogood J, et al. Relation between skin cancer and HLA antigens in renal-transplant recipients. N Engl J Med 1991;325:843-8.
6. Speerstra F, Boerbooms AM, van de Putte LB, van Beusekom HJ, Kruijsen MW, Vandenbroucke JP. Side-effects of azathioprine treatment in rheumatoid arthritis: analysis of 10 years of experience. Ann Rheum Dis 1982;41 Suppl 1:37-9.
7. Baltus JA, Boersma JW, Hartman AP, Vandenbroucke JP. The occurrence of malignancies in patients with rheumatoid arthritis treated with cyclophosphamide: a controlled retrospective follow-up. Ann Rheum Dis 1983;42:368-73.
8. Kinlen LJ. Incidence of cancer in rheumatoid arthritis and other disorders after immunosuppressive treatment. Am J Med 1985;78:44-9.
9. Silman AJ, Petrie J, Hazleman B, Evans SJ. Lymphoproliferative cancer and other malignancy in patients with rheumatoid arthritis treated with azathioprine: a 20 year follow up study. Ann Rheum Dis 1988;47:988-92.
10. Gridley G, McLaughlin JK, Ekbom A, Klareskog L, Adami HO, Hacker DO, et al. Incidence of cancer among patients with rheumatoid arthritis. J Nail Cancer Inst 1993;85:307-11.
11. Arellano F, Krupp P. Malignancies in rheumatoid arthritis patients treated with cyclosporin A. Br J Rheumatol 1993;32 Suppl 1:72-5.
12. Symmons D. Excess mortality in rheumatoid arthritis - is it the disease or the drugs? J Rheumatol 1995;22:2200-2.
13. Prior P, Symmons DP, Scott DL, Brown R, Hawkins CF. Cause of death in rheumatoid arthritis. Br J Rheumatol 1984;23:92-9.
14. Feutren G, Mihatsch MJ, for the International Kidney Biopsy Registry of Cyclosporine in Autoimmune Diseases. Risk factors for cyclosporine-induced nephropathy in patients with autoimmune diseases. N Engl J Med 1992;326:1654-60.
15. Scherrer U, Vissing SF, Morgan BJ, Rollins JA, Tindall RS, Ring S, et al. Cyclosporine-induced sympathetic activation and hypertension after heart transplantation. N Engl J Med 1990;323:693-9.
16. Mark AL. Cyclosporine, sympathetic activity, and hypertension. N Engl J Med 1990;323:748-50.
17. Van Rijthoven AW, Dijkmans BA, Goei The HS, Hermans J, Montnor-Beckers ZL, Jacobs PC, et al. Cyclosporin treatment for rheumatoid arthritis: a placebo controlled, double blind, multicentre study. Ann Rheum Dis 1986;45:726-31.
18. Van Rijthoven AW, Dijkmans BA, The HS, Meijers KA, Montnor-Beckers ZL, Moolenburgh JD, et al. Comparison of Cyclosporine and D-penicillamine for rheumatoid arthritis: a randomized, double blind, multicenter study. J Rheumatol 1991;18:815-20.
19. Landewé RBM, Goei The HS, van Rijthoven AWAM, Breedveld FC, Dijkmans BAC. A randomized, double-blind, 24-week controlled study of low-dose Cyclosporine versus chloroquine for early rheumatoid arthritis. Arthritis Rheum 1994;37:637-43.
20. Landewe RB, Goei The HS, van Rijthoven AW, Rietveld JR, Breedveld FC, Dijkmans BA. Cyclosporine in common clinical practice: an estimation of the benefit/risk ratio in patients with rheumatoid arthritis. J Rheumatol 1994;21:1631-6.
21. Ropes MW, Bennett CA, Cobb S, Jacox R, Jessar R. A revision of diagnostic criteria for rheumatoid arthritis. Bull Rheum Dis 1958;175-6.
22. Arnett FC, Edworthy SM, Bloch DA, McShane DJ, Fries JF, Cooper NS, et al. The American Rheumatism Association 1987 revised criteria for the classification of rheumatoid arthritis. Arthritis Rheum 1988;31:315-24.
23. Jones M, Symmons D, Finn J, Wolfe F. Does exposure to immunosuppressive therapy increase the 10 year malignancy and mortality risks in rheumatoid arthritis? A matched cohort study. Br J Rheumatol 1996;35:738-45.
24. Sheil AG. Cancer in organ transplant recipients: part of an induced immune deficiency syndrome. BMJ 1984;288:659-61.
25. Bachman TR, Sawitzke AD, Perkins SL, Ward JH, Cannon GW. Methotrexate-associated lymphoma in patients with rheumatoid arthritis: report of two cases. Arthritis Rheum 1996;39:325-9.